FDA Flags Repeat Nonconformities at Zimmer Biomet Facility

The GMP Letter
A A
The FDA posted a Form 483 flagging several GMP and MDR nonconformities — most of which are repeat observations — at a Zimmer Biomet medical device manufacturing facility in Indiana.

To View This Article:

Login

Subscribe To The GMP Letter